Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05135611

The Efficacy of the 4-channel Sequential NMES for the Treatment of Sleep Apnea

The Efficacy of the 4-channel Sequential NMES for the Treatment of Sleep Apnea, Single-center Prospective, Open Level, Pilot Study

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
11 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years – 60 Years
Healthy volunteers
Accepted

Summary

In the treatment of obstructive sleep apnea, by using sequential 4-channel electrical stimulation treatment, unlike conventional positive pressure devices, it can be done more effectively by improving the strength of the biceps and soft palate, which are the causes of sleep apnea. thought.

Detailed description

Design: Prospective study Inclusion criteria of patient group: Patients aged 19 to 60 years diagnosed with moderate to severe obstructive sleep apnea(n=11) Main outcome measures: AHI (apnea-hypoapnea index), Oxygen saturation lowering variables (minimum oxygen saturation, oxygen saturation time less than 90% (%), oxygen desaturation index (ODI) , REM sleep time and ratio of each). Satisfaction with sleep and discomfort of electrical stimulation treatment before and after treatment were evaluated on the Likert scale. Evaluate the state of health before and after electrical stimulation treatment through EQ-5D-5L.

Conditions

Interventions

TypeNameDescription
DEVICE4 channel Electrical Stimulation Deviceelectrical stimulation at muscles which related with sleep apnea,. 4-channel NMES is the protocol that provides sequential electrical stimulation to Rt. suprahyoid m (channel 1), Lt.suprahyoid m (channel 2), bilateral thyrohyoid m (channel 3), and biltateral sternothyroid m (channel 4). At this time, channels 1 and 2 start to contract first and stimulate for 1200ms, and channel 3 starts stimulation 150ms after channels 1 and 2, and applies stimulation for 1050ms. Channel 4 starts stimulation 250ms after stimulation of channels 1 and 2 and stimulates it for 950 ms.

Timeline

Start date
2022-07-05
Primary completion
2022-10-14
Completion
2024-06-30
First posted
2021-11-26
Last updated
2024-04-19

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05135611. Inclusion in this directory is not an endorsement.